SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-13-258414
Filing Date
2013-06-13
Accepted
2013-06-13 21:08:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 44150
2 GRAPHIC g528948g00n53.gif GRAPHIC 1621
3 GRAPHIC g528948g28s43.gif GRAPHIC 1636
4 GRAPHIC g528948g44b72.gif GRAPHIC 1628
5 GRAPHIC g528948g54r89.gif GRAPHIC 1618
6 GRAPHIC g528948g55c54.gif GRAPHIC 3205
7 GRAPHIC g528948g55m47.gif GRAPHIC 1617
8 GRAPHIC g528948g56h01.gif GRAPHIC 1632
9 GRAPHIC g528948g62s57.gif GRAPHIC 5140
10 GRAPHIC g528948g70l92.gif GRAPHIC 1621
  Complete submission text file 0001193125-13-258414.txt   73584
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations